DeepMind, a Google-owned AI research lab in London, has announced its plans to explore whether its technology can be used to help the NHS treat head and neck cancers.
Through a new partnership with University College London Hospital, the company's third with an NHS organization, Google DeepMind will aim
to establish whether machine learning techniques could reduce the amount
of time it takes to plan radiotherapy treatment for such cancers
Treating cancers that are found in the head and neck with
readiotherapy requires a great deal of precision. Clinicians must
"segment" the tumor from healthy tissue and feed this information into a
radiotherapy machine which then kills off the harmful cells.
Producing these detailed outlines can take clinicians up to four
hours but Google DeepMind thinks that this time could be slashed to
around an hour.
No comments:
Post a Comment